RANI Stock Analysis: Buy, Sell, or Hold?
RANI - Rani Therapeutics Holdings, Inc. Class A Common Stock
$0.90
0.02 (2.69%)
▲
5d:
-5.56%
30d:
+1.66%
90d:
-32.94%
HOLD
LOW Confidence
Analysis Updated: Jun 4, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Get Alerted When RANI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RANI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RANI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RANI is currently trading at $0.90, which is considered slightly low relative to its 30-day fair value range of $0.88 to $1.04.
Technical Outlook: Technically, RANI is in a strong downtrend. Immediate support is located at $0.82, while resistance sits at $1.12.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+734.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RANI is in a strong downtrend. Immediate support is located at $0.82, while resistance sits at $1.12.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+734.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.88 -
$1.04
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 734.6% below Wall St target ($7.50)
- CAUTION: Recommendation downgraded due to -5.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.88 -
$1.04
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.82
Resistance Level
$1.12
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.08
Wall Street Target
$7.50
(+734.6%)
Revenue Growth (YoY)
893.0%
Share & Embed Analysis
Last updated: June 05, 2026 9:29 AM ET
Data refreshes hourly during market hours. Next update: 10:29 AM
Data refreshes hourly during market hours. Next update: 10:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RANI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 58 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 67 BUY |
